Dosimetric Effectiveness of Targeted Radionuclide Therapy Based on a Pharmacokinetic Landscape (Q42961805)

11 November 2017

Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape (English)

1 reference

11 November 2017

Dosimetric Effectiveness of Targeted Radionuclide Therapy Based on a Pharmacokinetic Landscape (English)

1 reference

Crossref

https://api.crossref.org/works/10.1089/CBR.2009.0754

22 June 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

22 June 2024

radiometry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

modelling biological systems

22 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

22 June 2024

4

Robert Jeraj

1 reference

11 November 2017

Joseph J. Grudzinski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

22 June 2024

Ronald R. Burnette

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

22 June 2024

Jamey P. Weichert

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

22 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20735205

22 June 2024

publication date

1 August 2010

1 reference

full work available at URL

11 November 2017

https://europepmc.org/articles/pmc3787722?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20735205/pdf/?tool=EBI

22 June 2024

file format

Portable Document Format

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20735205/?tool=EBI

22 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

https://europepmc.org/articles/PMC3787722

22 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

https://europepmc.org/articles/PMC3787722?pdf=render

22 June 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

https://doi.org/10.1089/cbr.2009.0754

22 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735205

http://www.liebertpub.com/doi/full-xml/10.1089/cbr.2009.0754

22 June 2024

1 reference

Crossref

https://api.crossref.org/works/10.1089/CBR.2009.0754

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2009.0754

22 June 2024

1 reference

Crossref

https://api.crossref.org/works/10.1089/CBR.2009.0754

Cancer Biotherapy and Radiopharmaceuticals

22 June 2024

published in

1 reference

11 November 2017

25

1 reference

11 November 2017

4

1 reference

11 November 2017

417-426

1 reference

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Targeted therapy in nuclear medicine--current status and future prospects.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Targeted radionuclide therapy for neuroendocrine tumours

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Therapy with radiopharmaceuticals

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Options for radionuclide therapy: from fixed activity to patient-specific treatment planning

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Physical and chemical properties of radionuclide therapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Pharmacokinetic modeling and absorbed dose estimation for chimeric anti-CEA antibody in humans

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

On the correction for radioactive decay in pharmacokinetic modeling

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

26 May 2018

Pharmacokinetic modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Targeted radionuclide therapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Pharmacokinetic model-predicted anticancer drug concentrations in human tumors

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787722

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam

16 August 2018

1 reference

12 December 2020

Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma

1 reference

12 December 2020

Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma

1 reference

12 December 2020

An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan

1 reference

12 December 2020

Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives

1 reference

12 December 2020

Computerized three-dimensional segmented human anatomy

1 reference

12 December 2020

Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model

1 reference

12 December 2020

A theoretical four-compartment model to evaluate separate kidney technetium-99m-MAG3 kinetics in humans

1 reference

12 December 2020

MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee

1 reference

12 December 2020

Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH

1 reference

12 December 2020

Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma

1 reference

12 December 2020

Identifiers

1 reference

11 November 2017

1 reference

11 November 2017

1 reference